The antimony assays from October 2023 are very impressive, and potentially valuable. But in the most recent Quarterly there is no mention of antimony that I can see. And it seems because of that many shareholders, including myself, have forgotten about it. It would be really good to see a resource estimate for this Antimony. As it happens, we now see the share price rising well, possibly blown by the Directors getting their shares at 4.5c. Are they thinking only gold, or is something moving for antimony.?
FXG Price at posting:
5.1¢ Sentiment: Hold Disclosure: Held
